Zhang Peng, Chen Yantang, Zheng Weihao, Wu Meimei, Wu Zhentao, Lu Yuting, Zhang Shuang, Zhang Xin, Huang Yanming
Department of Critical Care Medicine, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China.
Department of Medical Research Center, Jiangmen Central Hospital, Jiangmen 529030, Guangdong, China.
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Sep;33(9):1063-1068. doi: 10.3760/cma.j.cn121430-20210414-00558.
To analyze the differences and similarities of pre-treatment and post-treatment lung microbiome of acute respiratory distress syndrome (ARDS) and find out the change rules of the lung microbiome in the progression of ARDS according to different prognosis.
A retrospective study was conducted. Patients with ARDS caused by severe pneumonia admitted to intensive care unit (ICU) of Jiangmen Central Hospital from February 2019 to January 2020 were enrolled as the study subjects. The patients were divided into pre-treatment (ARDS-preT) group (24 cases), post-treatment survival (ARDS-poT-Survival) group (17 cases), and post-treatment death (ARDS-poT-Dead) group (7 cases). ICU patients with mild pulmonary infection and non-ARDS admitted to ICU during the same period were enrolled as control group (25 cases). The similarities and differences of lung microbiome in four groups were analyzed and compared, and the possible pathogenic bacteria (potential risk factors for death) and probiotics (potential survival and protective factors) related to death caused by ARDS were screened.
In terms of pathogenic microorganisms, the positive rates of Escherichia coli and Candida albicans in the ARDS-poT-Dead group were significantly higher than those in the ARDS-poT-Survival group [57.1% (4/7) vs. 5.9% (1/17) and 57.1% (4/7) vs. 0% (0/7), both P < 0.05]. In the screening of background bacteria, the decrease of bacteria in the ARDS-preT group compared with the ARDS-poT-Survival group, the ARDS-poT-Dead group compared with the ARDS-poT-Survival group, the ARDS-poT-Dead group compared with the control group, the reduced bacteria might be pulmonary probiotics (potential protective factor for ARDS). The screening result was Hydrobacter [ARDS-preT group vs. ARDS-poT-Survival group: 62.5% (15/24) vs. 94.1% (16/17); ARDS-poT-Dead group vs. ARDS-poT-Survival group: 14.3% (1/7) vs. 94.1% (16/17); ARDS-poT-Dead vs. control: 14.3% (1/7) vs. 96.0% (24/25), all P < 0.05]. In the screening of background bacteria, the increase of bacteria in the ARDS-poT-Dead group compared with the ARDS-preT group, the ARDS-poT-Dead group compared with the ARDS-poT-Survival group, the ARDS-poT-Dead group compared with the control group, and the increased bacteria might be potential pulmonary pathogen (potential risk factor for death of ARDS), which belonged to Enterobacteria: Edwardsiella, Enterobacteriaceae, Escherichia, Klebsiella, Kluyvera, Lelliottia, Pantoea, Raoultella.
The results revealed the increase of Escherichia coli or Candida albicans in pulmonary pathogenic microorganisms, or the increase of Enterobacteria in background bacteria may be the risk factors for the death of ARDS. Additionally, background bacteria Hydrobacter probably is a protective factor for the survival of ARDS. Whether it can be used as a novel treatment for ARDS is worth further investigation.
分析急性呼吸窘迫综合征(ARDS)治疗前后肺部微生物群的异同,并根据不同预后找出ARDS进展过程中肺部微生物群的变化规律。
进行一项回顾性研究。将2019年2月至2020年1月在江门市中心医院重症监护病房(ICU)收治的重症肺炎所致ARDS患者纳入研究对象。患者分为治疗前(ARDS-preT)组(24例)、治疗后存活(ARDS-poT-Survival)组(17例)和治疗后死亡(ARDS-poT-Dead)组(7例)。同期入住ICU的轻度肺部感染且非ARDS的ICU患者作为对照组(25例)。分析比较四组肺部微生物群的异同,筛选与ARDS所致死亡相关的可能病原菌(死亡潜在危险因素)和益生菌(潜在生存及保护因素)。
在致病微生物方面,ARDS-poT-Dead组中大肠杆菌和白色念珠菌的阳性率显著高于ARDS-poT-Survival组[分别为57.1%(4/7)对5.9%(1/17)和57.!%(4/7)对0%(0/7),均P<0.05]。在背景菌筛选中,ARDS-preT组与ARDS-poT-Survival组相比、ARDS-poT-Dead组与ARDS-poT-Survival组相比、ARDS-poT-Dead组与对照组相比,细菌减少,减少的细菌可能是肺部益生菌(ARDS潜在保护因素)。筛选结果为嗜水气单胞菌[ARDS-preT组对ARDS-poT-Survival组:62.5%(15/24)对94.1%(16/17);ARDS-poT-Dead组对ARDS-poT-Survival组:14.3%(1/7)对94.1%(16/17);ARDS-poT-Dead组对对照组:14.3%(1/7)对96.0%(24/25),均P<0.05]。在背景菌筛选中,ARDS-poT-Dead组与ARDS-preT组相比、ARDS-poT-Dead组与ARDS-poT-Survival组相比、ARDS-poT-Dead组与对照组相比,细菌增加,增加的细菌可能是潜在肺部病原菌(ARDS死亡潜在危险因素),属于肠杆菌科:爱德华氏菌属、肠杆菌属、大肠杆菌属、克雷伯菌属、克吕韦氏菌属、勒氏菌属、泛菌属、拉乌尔菌属。
结果显示肺部致病微生物中大肠杆菌或白色念珠菌增加,或背景菌中肠杆菌增加可能是ARDS死亡的危险因素。此外,背景菌嗜水气单胞菌可能是ARDS存活的保护因素。其能否作为ARDS的新型治疗手段值得进一步研究。